Abstract:Background Perfluoroalkyl and polyfluoroalkyl substances (PFASs) have been reported to suppress immune function. However, previous studies on prenatal exposure to PFASs and allergic disorders in offspring provided inconsistent results. We aimed to examine the association between prenatal exposure to PFASs and childhood atopic dermatitis (AD) in offspring up to 24 months of age. Methods A prospective birth cohort study involving 1056 pregnant women was conducted in two hospitals in Shanghai from 2012 to 2015. Prenatal information was collected by an interview with the women and from medical records. Fetal umbilical cord blood was collected at birth. Cord blood plasma PFASs were measured. Children were followed at 6, 12 and 24 months and information on the development of AD was recorded. AD was diagnosed by 2 dermatologists independently based on the questionnaires. Multiple logistic regression was used to compute odds ratio (OR) and corresponding 95% confidence interval (CI) for the association between AD and each PFASs, adjusting for potential confounders . Results A total of 687 children completed a 2-year follow-up visit and had PFASs measurement. AD was diagnosed in 173 (25.2%) children during the first 24 months. In female children, a log-unit increase in perfluorooctanoic acid (PFOA) was associated with a 2.1-fold increase in AD risk (AOR 2.07, 95% CI 1.13–3.80) after adjusting for potential confounders. The corresponding risk was 2.22 (1.07–4.58) for perfluorononanoic acid (PFNA). The highest PFOA quartile was significantly associated with AD (2.52, 1.12–5.68) compared with the lowest quartile. The highest quartile of PFNA, perfluorodecanoic acid (PFDA) and perfluorohexane sulfonic acid (PFHxS) were associated with AD with AOR (95% CI) being 2.14 (0.97–4.74), 2.14 (1.00–4.57), and 2.30 (1.03–5.15), respectively. Additionally, the second quartile of perfluorododecanoic acid (PFDoA) was associated with a 3.2-fold increase in AD risk (3.24, 1.44–7.27). However, no significant associations were found in male children. Conclusions Prenatal exposure to PFOA, PFDA, PFDoA and PFHxS significantly increased the risk of childhood AD in female children during the first 24 months of life. In addition, the associations between AD with prenatal exposure to PFNA were close to statistical significance.

Inactivation of common airborne antigens by perfluoroalkyl chemicals modulates early life allergic asthma

Perfluorooctanesulfonate and perfluorooctanoate exacerbate airway inflammation in asthmatic mice and in vitro

Childhood Co‐exposure of Cold Stress and PM2.5 Aggravates the Susceptibility and Severity of Asthma in Adulthood of Mice

LPS Inactivation by a Host Lipase Allows Lung Epithelial Cell Sensitization for Allergic Asthma

Associations of serum perfluoroalkyl acid levels with T-helper cell-specific cytokines in children: By gender and asthma status

Airway Exposure to Perfluorooctanoate Exacerbates Airway Hyperresponsiveness and Downregulates Glucocorticoid Receptor Expression in Asthmatic Mice

PM2.5 exposure and cold stress exacerbates asthma in mice by increasing histone acetylation in IL-4 gene promoter in CD4+ T cells.

Developmental PFOS exposure alters lung inflammation and barrier integrity in juvenile mice

Mechanisms of exacerbation of Th2-mediated eosinophilic allergic asthma induced by plastic pollution derivatives (PPD): A molecular toxicological study involving lung cell ferroptosis and metabolomics

Perfluoroalkyl Substances (PFAS) Affect Inflammation in Lung Cells and Tissues

Association Between Prenatal Exposure to Perfluoroalkyl Substances and Asthma-Related Diseases in Preschool Children.

Maternal microbiome regulation prevents early allergic airway diseases in mouse offspring

Emerging and legacy per- and polyfluoroalkyl substances in house dust from South China: Contamination status and human exposure assessment

Early-life infection of the airways with Streptococcus pneumoniae exacerbates HDM-induced asthma in a murine model

Asthma and decreased lung function in children exposed to perfluoroalkyl and polyfluoroalkyl substances (PFAS): An updated meta-analysis unveiling research gaps

Prenatal exposure to perfluorooctanoic acid and childhood allergic diseases: a prospective birth cohort study

Childhood co‐exposure of cold stress and PM 2.5 aggravates the susceptibility and severity of asthma in adulthood of mice

Associations between prenatal exposure to per- and polyfluoroalkyl substances and plasma immune molecules in three-year-old children in China

Prenatal exposure to perfluoroalkyl and polyfluoroalkyl substances and childhood atopic dermatitis: a prospective birth cohort study

Global quantification of emerging and legacy per - and polyfluoroalkyl substances in indoor dust: Levels, profiles and human exposure

Impact of pesticide cocktail on development and severity of allergic asthma